$8.66
-0.08-0.92%
Last update: Oct 7, 6:02 AM
$8.85
0.111.26%
Vicore Pharma Holding AB (VCRE) Stock Price, Quote, News & History
VCRENASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Vicore Pharma Holding (NASDAQ:VCRE) through any online brokerage.
Other companies in Vicore Pharma Holding’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
There is no analysis for Vicore Pharma Holding to provide a consensus price target.
The stock price for Vicore Pharma Holding (NASDAQ: VCRE) is $8.85 last updated October 7, 2026 at 6:02 AM EDT.
There are no upcoming dividends for Vicore Pharma Holding.
Vicore Pharma Holding does not have any upcoming earnings scheduled.
There is no upcoming split for Vicore Pharma Holding.
Vicore Pharma Holding is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an...
